Barclays PLC vs Johnson & Johnson — how do they compare? Barclays PLC trades at $28 (market cap $93.87B), while Johnson & Johnson trades at $260.13 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 6.7× Barclays PLC's market cap, and Barclays PLC pays the higher dividend (2.19%). Which is the better fit depends on your goals.
| BCS | JNJ | |
|---|---|---|
Market Cap | $93.87B | $626.09B |
Sector | Financials | Health |
52-Week High | $28.56 | $267.24 |
52-Week Low | $19.36 | $172.78 |
Dividend Yield | 2.19% | 2.06% |
Volume | — | 6,156,228 |
Enterprise Value | — | $654.37B |
Signals from Pluang's Aura AI — not financial advice
Barclays PLC (BCS) trades at $27.98, up 0.18% today, with a bullish technical signal from moving averages and neutral oscillators. The stock shows strong fundamentals, including a P/E of 10.68, P/B of 0.88, and net income margin of 25.51%, with Q2 2026 EPS beating estimates at $0.90. Recent news highlights a 17% profit jump in H1 2026 but also a securities class action investigation, creating mixed sentiment.
The outlook is cautiously optimistic, supported by earnings beats and a 68% analyst buy rating, but risks include cost pressures, legal scrutiny, and market volatility. Upside potential hinges on sustained profit growth and efficient cost management amid economic uncertainties.
Johnson & Johnson (JNJ) trades at $261.81, up 0.99% on the day and near its 52-week high. The stock exhibits bullish technical signals with strong moving average support, while fundamentals show robust profitability with a net income margin of 21.48% and consistent dividend growth. Recent earnings have mostly beaten expectations, and the company maintains a solid balance sheet with $24.52 billion in cash.
The outlook for JNJ remains positive, supported by analyst consensus and a price target of $284.50. Key opportunities include its defensive healthcare positioning and pipeline strength, though risks involve patent expirations and legal headwinds. The stock offers a stable investment with growth potential in a volatile market.
Trailing returns across standard periods
Latest headlines on both assets
Barclays is a universal bank headquartered in the United Kingdom. It operates via two principal segments
Read more on BCS →Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →